1. Home
  2. BAND vs PHAR Comparison

BAND vs PHAR Comparison

Compare BAND & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$68.55

Market Cap

771.9M

Sector

Technology

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.55

Market Cap

917.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAND
PHAR
Founded
2000
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
771.9M
917.4M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
BAND
PHAR
Price
$68.55
$12.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$24.50
$38.33
AVG Volume (30 Days)
1.2M
13.8K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$204,113,000.00
N/A
Revenue This Year
$15.16
$10.04
Revenue Next Year
$6.18
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
25.26
N/A
52 Week Low
$12.50
$9.54
52 Week High
$71.76
$21.34

Technical Indicators

Market Signals
Indicator
BAND
PHAR
Relative Strength Index (RSI) 77.48 35.59
Support Level $14.27 $11.84
Resistance Level N/A $13.44
Average True Range (ATR) 4.61 0.42
MACD 0.38 0.09
Stochastic Oscillator 82.85 33.16

Price Performance

Historical Comparison
BAND
PHAR

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of its revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: